ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 50 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 5,800 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 5,800 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 5,800 | -1.7% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 5,900 | -0.3% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 5,918 | +0.3% | 0.00% | – |
| Q1 2021 | $8,000 | +100.0% | 5,900 | +103.4% | 0.00% | – |
| Q4 2020 | $4,000 | -50.0% | 2,900 | -46.3% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 5,400 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | -84.7% | 5,400 | -63.6% | 0.00% | – |
| Q3 2019 | $59,000 | -11.9% | 14,854 | -9.5% | 0.00% | – |
| Q2 2019 | $67,000 | +219.0% | 16,416 | +435.9% | 0.00% | – |
| Q1 2019 | $21,000 | -41.7% | 3,063 | -53.8% | 0.00% | – |
| Q4 2018 | $36,000 | +33.3% | 6,627 | +157.2% | 0.00% | – |
| Q3 2018 | $27,000 | +12.5% | 2,577 | +38.3% | 0.00% | – |
| Q2 2018 | $24,000 | +500.0% | 1,863 | +355.5% | 0.00% | – |
| Q1 2018 | $4,000 | -42.9% | 409 | -40.5% | 0.00% | – |
| Q4 2017 | $7,000 | – | 687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
| AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
| Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
| Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
| Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
| Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
| PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |